Stuart Duty - 28 Aug 2024 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Reporting relationship: Director
Issuer ticker: MIST
Reported as of: 28 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Aug 2024, 16:15:14 UTC
Prior SEC filing: 17 Jul 2024
Next SEC filing: 07 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Jason Minio, Attorney-in-Fact

Key filing fact

Stuart Duty filed Form 4 for Milestone Pharmaceuticals Inc. (MIST) on 29 Aug 2024.

Key facts

This page summarizes Stuart Duty's Form 4 filing for Milestone Pharmaceuticals Inc. (MIST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Aug 2024, 16:15.

Change

Previous filing in this sequence was filed on 17 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIST transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +40,000
Change %
Price: $0.000000
Shares after: 40,000
Date: 28 Aug 2024
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 40,000
Exercise price: $1.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.